Research Alert: CFRA Keeps Sell View On Shares Organon & Co

MT Newswires02:55

Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $15

Futu News02:31 · Ratings

BofA Securities Maintains Organon & Co(OGN.US) With Sell Rating, Announces Target Price $11

Futu News02:31 · Ratings

Express News | Organon & Co : BofA Global Research Cuts Price Objective to $11 From $15

BreakingsApr 21 23:15

BofA Securities Adjusts Price Target on Organon to $11 From $15, Maintains Underperform Rating

MT NewswiresApr 21 23:12 · Ratings

OgaLong collaborates with multiple retail partners to jointly promote the scientific management of gout throughout its entire cycle.

On the occasion of World Gout Day on April 20, the global leading healthcare company Ogalon, in collaboration with the well-known chain pharmacy Gaoji Health and the online medication platform Meituan Buy Medicine, calls for the integration of retail health management advantages of SSE Select Resources Industries Index, extending the full-chain health management for gout patients from hospitals to outside hospitals, providing patients with more "accessible" Professional Services. This call not only responds to the national policy direction for refined management of chronic diseases but also embodies the collaborative efforts to enhance the level of grassroots medical services.

PR NewswireApr 18 15:23